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We isolated two recombinant baculoviruses each of which expresses a varicella-zoster virus (VZV) homolog of one of 
the seven herpes simplex virus type 1 (HSV-1) genes required for DNA replication. We performed transient origin-dependent 
DNA replication assays in insect cells in which we substituted a baculovirus which expresses a VZV protein for a baculovirus 
which expresses its HSV homolog. VZV gene 51 protein was found to be able to support origin-dependent DNA synthesis 
when it was substituted for ULg, the HSV-1 origin-binding protein (QBP). This occurred whether an HSV-1 or a VZV origin* 
containing plasmid was used in the assay. These results suggest that VZV gene 51 protein is able to interact with the HSV 
replication machinery, and in light of the extensive structural divergence of these proteins, it suggests that initiation of VZV 
and HSV-1 DNA synthesis may involve a limited number of interactions between the OBP and other replication factors. 
Substitution of infected-cell protein 8 (ICP8), the major single-stranded DNA-binding protein of HSV-1, with VZV gene 29 
protein, however, did not result in amplification of plasmids containing either an HSV-1 or a VZV origin. In the absence of 
ICPS, addition of both VZV gene 51 protein and gene 29 protein was also negative for origin-dependent replication whether 
or not UL9 was present. Although demonstration that our baculovirus-expressed VZV gene 29 protein is functional for DNA 
replication will await development of a VZV replication system, our results suggest that VZV gene 29 protein is unable to 
interact functionally with one or more of the HSV replication proteins. This approach should contribute to efforts to define 
the interactions among the alphaherpesvirus DNA replication 3roteins. © 1995 Academic Press, Inc. 
Herpesviruses, which have large linear DNA genomes, 
provide excellent model systems for eukaryetic DNA rep- 
lication studies, Herpes simplex virus type 1 (HSV-1), the 
best characterized of the herpesviruses, has a 152-kbp 
genome which contains well-defined origins of replica- 
tion and encodes seven genes which have been shown 
to be required for viral DNA synthesis (1-4). UL30 and 
UL42 encode the catalytic and accessory subunits of 
the DNA polymerase complex. UL29 encodes the major 
single-stranded DNA-binding (SSB) protein, infected-cell 
protein 8 (ICP8). UL5, UL8, and UL52 encode three poly- 
peptides which make up the heterotrimeric helicase- 
primase complex. Finally, UL9 encodes the origin of DNA 
replication-binding protein (OBP). Much of the biochemi- 
cal characterization of these replication proteins has 
been done using protein made in insect cells infected 
with recombinant baculoviruses. Unfortunately, a cell- 
free HSV origin-dependent replication system has not yet 
been developed with which to test the ability of these 
insect cell-produced proteins to support origin-depen- 
dent DNA synthesis. This had raised concerns that one 
or more of these proteins may not be fully functional for 
DNA synthesis. This concern was recently eliminated 
when Stow demonstrated HSV-1 origin-dependent DNA 
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replication in insect cells infected with a mixture of seven 
baculoviruses each of which expresses one of the seven 
essential replication genes (5). Stow suggested that this 
method would be valuable for testing the function of ba- 
culovirus-expressed mutant proteins. We decided to take 
advantage of this approach to test the ability of varicella- 
zoster virus (VZV) DNA replication proteins to substitute 
for their HSV-1 counterparts, both as a way of testing the 
function of the VZV proteins and as a means of compar- 
ing the two systems. 
VZV is a human herpesvirus which, like HSV-1, belongs 
to the subfamily AIphaherpesvirinae (6). Despite signifi- 
cant differences in their biologic behavior, VZV and HSV- 
1 share many structural and molecular biological fea- 
tures. It has been reported, for example, that certain VZV 
immediate-early genes can complement heir HSV-1 ho- 
mologs (7, 8). The 125-kbp linear, double-stranded DNA 
VZV genome has a homolog to each of the seven essen- 
tial HSV-1 replication proteins (3, 9). Unlike HSV-1, how- 
ever, there have been very few genetic studies on VZV 
DNA replication genes, and there are no VZV mutants 
with lesions in the presumed essential replication genes. 
The VZV genome has no equivalent to the HSV-1 origin 
termed oriL, but, like HSV, the VZV genome has two cop- 
ies of otis in the inverted repeats flanking the short 
unique region of the genome (9, 10). Although VZV origin- 
dependent plasmid replication has been described in 
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VZV-infected cells, there has been no report of origin- 
dependent replication using isolated VZV replication 
genes (10). Stow and Davison showed that a plasmid 
containing VZV oris was amplified in both VZV- and HSV- 
1 infected cells, but a plasmid containing an HSV-1 oris 
was not amplified in VZV-infected cells (10). 
VZV gene 51 encodes a protein which is homologous 
to UL9, the HSV-10BP, which is thought to play an im- 
portant role in initiation of viral DNA synthesis (11, •2). 
Using a protein A fusion protein it was shown that, as 
with UL9, the origin-binding domain of the VZV OBP maps 
to the carboxyl terminus (13). It is likely that the VZV ©BP 
plays the same role as UL9 during viral DNA replication, 
but there are no genetic data to support this idea, and 
origin-binding activity has not been identified in extracts 
of VZV-infected cells: Recently, we reported expression 
of the full-length VZV QBP by in vitro translation and 
showed that the VZV and HSV-10BP have virtually identi- 
cal recognition sequences (14). 
VZV gene 29 is the homolog of UL29 which encodes 
lOP8, the major SSB protein of HSV-1 (15-17). lOP8 is 
probably involved in several stages of viral DNA synthe- 
sis. lOP8 can melt partially duplex DNA in the absence 
of ATP and magnesium in a manner similar to other SSBs 
(18). In doing so it may facilitate the activity of helicases 
such as the origin-binding protein, UL9, and the heli- 
case-primase complex made up of ULS, UL8, and UL52. 
It has been shown to physically interact with and en- 
hance the helicase activity of UL9 and thus may facilitate 
origin unwinding (18, 19). It also promotes movement 
of the HSV-1 DNA polymerase through hairpins on the 
template strand during elongation (20, 21). We have 
found that VZV gene 29 protein has similar single- 
stranded DNA-binding properties as ICP8, but there are 
no genetic or biochemical data about its interactions with 
other proteins or about any other possible functions (M. 
Horgan and P. D. Olivo, submitted for publication). 
In this report we describe results of transient origin- 
dependent DNA replication assays in Spodoptera frugi- 
perda (sfg) insect cells infected with seven recombinant 
baculoviruses in which we substituted a baculovirus 
which expresses a VZV protein for a baculovirus which 
expresses its HSV homolog. Substitution of HSV-1 ICP8 
with VZV gene 29 protein did not result in amplification 
of plasmids containing either the HSV-1 or VZV origin, 
but VZV gene 51 protein was found to be able to support 
origin-dependent DNA synthesis when it was substituted 
for UL9. 
VZV genes 29 and 52 were subcloned from the BamHI 
D and EcoRI B VZV genomic fragments, respectively, ob- 
tained from L. Gelb (Washington University) (22) and were 
cloned into vector pVL1392 (23, 22). Recombinant bacu- 
Ioviruses which express VZV gene 29 protein (AcNPV/ 
29) and gene 51 protein (AcNPV/51) were constructed by 
using standard methods (23). Figure 1A is a fluorogram of 
an SDS-PAGE analysis of [35S]methionine-labeled pro- 
teins made in recombinant baculovirus-infected insect 
cells illustrating the expression of gene 51 protein (lane 
2) and gene 29 protein (lane 3) in insect cells infected 
with AcNPV/51 and AcNPV/29, respectively. Also shown 
is the expression of the HSV-1 homolog of gene 51 pro- 
tein (UL9, lane 1) and the homolog of gene 29 protein 
(ICP8, lane 4) in insect cells infected with AcUL9 and 
AcUL29(ICP8) (5). Gene 51 protein produced by in vitro 
transcription/translation was previously shown to have a 
relative migration in SDS-PAGE consistent with a poly- 
peptide of 85 kDa (14). This same size protein can be 
seen in AcNPV/51-infected cells (lane 2) and is absent 
in the AcULg-infected cells which display the slower mi- 
grating UL9 protein (lane 1). Figure 1B shows that the 
85-kDa gene 51 protein reacted with a rabbit anti-UL9 
antisera generated with a carboxyl-terminal peptide (2) 
(Fig. 1B, lane 2). Both proteins also reacted with a rabbit 
anti-gene 51 protein antiserum generated with a car- 
boxyl-terminal peptide (data not shown) (14). The cross- 
reactivity of both antisera is not surprising given the de- 
gree of predicted homology at the carboxyl termini of 
these proteins (14). Insect cell-expressed gene 51 protein 
did not react, however, with an antiserum generated with 
dodecapeptide derived from the predicted primary se- 
quence of the amino terminus of UL9 (data not shown). 
Gene 29 protein migrates with a relative mobility in SDS- 
PAGE consistent with a polypeptide of 135 kDa, which 
is larger than the 130-kDa lOP8 (Fig. 1A, lane 4). Insect 
cell-produced gene 29 protein reacted with a rabbit anti- 
serum generated against a peptide the sequence of 
which was derived from the predicted carboxyl terminus 
of gene 29 protein (24). 
We first wished to demonstrate HSWl origin-depen- 
dent DNA replication in insect cells using the assay de- 
veloped by Stow (5). Sf9 cells were transfected with plas- 
mid pUC19 or with pUC19 into which was inserted a 230- 
bp Smal fragment containing the HSV-1 oris (pMC110), 
and the cells were coinfected with the complete set of 
HSV-1 replication protein-producing baculoviruses. Six 
hours after transfection the cells were infected with vari- 
ous mixtures of recombinant baculoviruses. Sixty-five 
hours after infection total cellular DNA was harvested 
and digested with BamHI to linearize the plasmid. The 
sample was divided in two, and one half was digested 
with Dpnl to detect the presence of replicated (Dpnl- 
resistant) plasmid DNA. Following electrophoresis, the 
gel was transferred to a nylon membrane and hybridized 
using the oris plasmid as the probe. As can be seen in 
Fig. 2, pUC19 was not amplified under these conditions 
(lane 1). pMC110 was amplified following infection with 
the complete set of viruses (lane 3), but not if AcUL9 was 
left out of the baculovirus mixture (lane 5). We confirmed, 
therefore, the results of Stow that baculovirus-infected 
Sf9 ceils do not exhibit nonspecific plasmid amplification 
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FIG. 1. Expression of gene 51 protein and gene 29 protein in Sf9 cells. (A) Fluorogram of [35S]methionine-labeled proteins from recombinant 
baculovirus-infected cells analyzed by SDS-PAGE. The cells were infected with the indicated baculoviruses at an m.o.i, of at least 5. Sixty hours 
after infection the medium was removed and replaced with 1 ml methionine-free Grace's medium with 50 mCi [3~S]methionine (1000 Ci/mmol; 
Amersham, Arlington Heights, IL) for an additional 4 hr. The cells were then scraped into the medium, pelleted, washed two times in Grace's 
medium, and resuspended in SDS-PAGE sample buffer and an aliquot was submitted to SDS-PAGE. Following electrophoresis the gel was soaked 
in Amplify (Amersham), dried, and exposed to X-ray film. Lane 1, AcUL9-infected ceils; lane 2, AcNPV/51-infected cells; lane 3, AcNPV/29-infected 
cells; lane 4, AcUL29(ICPS)-infected cells. Closed squares to the left of each lane indicate the recombinant proteins. (B)Western blot of protein 
produced in AcNPV/51- and AcUL9-infected insect cells using rabbit anti-UL9 carbexy-terminal peptide antisera. Lane 1, mock-infected cell extract; 
lane 2, AcNPV/51-infected cell extract; lane 3, AcUL9-infected cell extract; lane 4, wild-type AcNPV-infected cell extract. (C) Western blot of protein 
produced in AcNPV/29- and AcUL29(iCP8)-infected insect cells using rabbit anti-gene 29 protein carboxyl-terminal peptide antisera. Lane 1, mock- 
infected cell extract; lane 2, AcNPV/29-infected cell extract; lane 3, AcUL29(ICP8)-infected cell extract. Size markers are indicated on the left (in 
kDa). 
and that HSV-1 origin-dependent plasmid replication re- 
quires coinfection with all seven of the baculoviruses 
which express the required HSV-1 replication proteins. 
Having reproduced HSV-1 origin-dependent replica- 
tion in insect cells, we wished to determine whether 
baculoviruses expressing the VZV replication proteins 
could substitute for those which express their HSV-1 ho- 
mologs. As shown in Fig. 2, Dpnl-resistant pMC110 was 
produced in Sf9 cells coinfected with six baculoviruses 
expressing HSV-1 proteins, but with AcNPV/51 added in 
place of AcUL9 (lane 7). AcNPV/29, however, was not 
able to substitute for AcUL29(ICPS) (lane 11). 
In order to demonstrate that VZV gene 29 protein was 
expressed in the coinfected cells, we [35S]methionine- 
labeled coinfected cells and analyzed cell extracts made 
from multply infected insect cells by SDS-PAGE and 
fluorography. We were able to demonstrate a band corre- 
sponding to each of the seven HSV-1 replication proteins 
in the insect cells infected with all seven HSV-1 recombi- 
nant baculoviruses, and in the instances in which 
AcNPV/51 or AcNPv/29 was substituted for AcUL9 or 
AcUL29(ICPS), a band comigrating with gene 51 protein 
or gene 29 protein was seen (data not shown). The ex- 
pression of gene 51 protein and gene 29 protein in the 
multiply infected cells was also directly demonstrated by 
Western blotting (data not shown). The absence of HSV- 
1 origin-dependent replication in experiments in which 
AcUL29(ICP8) is replaced by AcNPV/29 protein is not, 
therefore, due to lack of expression of gene 29 protein 
or of any of the HSV-1 replication proteins. 
ICP8 is a multifunctional protein which probably has 
several functions during viral DNA replication. It has been 
shown to specifically interact with UL9 and the DNA poly- 
merase and probably interacts with the UL5/8/52 heli- 
case-primase. One possible reason that gene 29 protein 
is unable to functionally substitute for ICP8 may be that 
it can not productively interact with one or more of the 
HSV-1 replication proteins. We, therefore, asked whether 
the presence of gene 51 protein, with or without the 
presence of UL9, could overcome the inability of gene 
29 protein to replace ICP8. Figure 3 demonstrates that 
pMC110 was converted to Dpnl resistance in insect cells 
only when ICP8 was included in the virus mixture. Lane 
1 demonstrates that the seven HSV-1 baculovirus system 
is functional, and lane 11 shows that AcNPV/51 virus 
stock used in this set of experiments is able to replace 
AcUL9. However, we detected no pMC1 10 amplification 
when lOP8 was left out of the mixture (lane 3), when 
gene 29 protein was substituted for ICP8 (lane 5), when 
both UL9 and ICP8 were replaced with gene 51 protein 
and gene 29 protein, respectively (lane 7), and when lOP8 
was replaced with gene 29 protein and both UL9 and 
gene 51 protein were added to the mixture (lane 9). 
Another possible reason that gene 29 protein is unable 
to functionally replace lOP8 could be because we have 
been using an HSV-1 origin rather than a VZV origin. It 
seemed unlikely that a nonspecific single-stranded DNA- 
binding protein such as gene 29 protein would exhibit 
origin specificity, particularly since the origin-binding 
proteins were interchangeable for HSV-1 origin-depen- 
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Iov i ruses  on ly  when ICP8 was  inc luded  (see lanes  1 and 
4). There fore ,  us ing a p lasmid  conta in ing  a VZV or ig in  
did not overcome the inabi l i ty  of gene  29 prote in  to re- 
p lace  lOP8 ( lane 11). 
VZV gene  51 prote in  shares  s t ructura l  features  wi th  
UL9. The i r  p red ic ted  amino  acid sequences  have  44% 
identity,  they  have  severa l  sequence  mot i fs  in common,  
and the s i te -spec i f i c  o r ig in -b ind ing  domain  of both pro- 
te ins  map to the carboxy l  te rminus  (13, 14, 25, 26). They  
a lso  have  been  shown to have  v i r tua l ly  ident ica l  or ig in-  
recogn i t io f l  sequences  (14). It is still somewhat  surpr is -  
ing, g iven the degree  of sequence  d ivergence  of the two  
prote ins ,  that  gene  51 prote in  can subst i tu te  for UL9. 
Gene  51 prote in  ext rac ted  f rom bacu lov i rus - in fec ted  in- 
sect  ce l ls  is inso lub le ,  and thus,  we  have  not  been  ab le  
to use it as a source  of mater ia l  to per fo rm a b iochemica l  
character i za t ion  of gene  51 prote in  (D. Chen and P. D. 
Ol ive,  unpub l i shed  observat ion) .  The  or ig in - rep l i ca t ion  
resul ts  p resented  here  are, there fore ,  our  on ly  ev idence  
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FIG. 2. Plasmid amplification in recombinant baculovirus-infected in- 
sect cells demonstrating the HSV-1 origin-dependence of replication 
and the ability of VZV gene 51 protein to substitute for UL9. Monolayers 
of Sf9 cells in six-well tissue culture plates (approximately 1 x 106 
cells/well) were transfected with 1 #g of either pUC19 or pMC110 using 
5 fig Lipofectin (Gibco BRL, Inc., Bethesda, MD) in Grace's medium. 
Six hours after transfection the ceils were coinfected with the indicated 
recombinant baculoviruses in a volume of 0.5 to 1.4 mt complete me- 
dium using a m.o.i, of at least 5 for each virus. After 2 hr at 27 ° , the 
inoculum was replaced with 2 ml complete Grace's media and the cells 
were incubated at 27 ° for 63-65 hr. Total cellular DNA was extracted 
by the method of Challberg (4). One-fourth of the total DNA extracted 
from each well was cleaved with BamHI alone or with BamHI and Dpnl. 
The fragments were separated by electrophoresis in a 1% agarose gel 
and transferred to Magnagraph membrane (MSI, Westboro, MA). The 
DNA was hybridized and detected using the Genius System (Boehr- 
inger-Mannheim, indianapolis, IN) according to the manufacturer's in- 
structions. The probe was pMC110 which was labeled using a random 
primer protocol with digoxigenin-tagged nucleotides. Hybridized probe 
was detected with alkaline phosphatase-conjugated anti-digoxigenin 
antibody and visualized with Lumi-Phos 530, a chemiluminescent sub- 
strate, followed by exposure to X-ray film. The "+" and "-"  above each 
lane indicates that the sample was digested (--) with the restriction 
enzyme Dpnl or not digested (-). Lanes 1 and 2, insect cells were 
transfected with pUC19; lanes 3-12, insect cells were transfected with 
pMC110 (HSV-1 otis); lanes 1-4, infection with the complete mixture 
of baculoviruses expressing the seven essential HSV-1 replication pro- 
teins; lanes 5 and 6, omission of AcUL9; lanes 7 and 8, omission of 
AcUL9 and addition of AcNPV/51; lanes 9 and 10, omission of AcUL29 
(lOP8); lanes 11 and 12, omission of AcUL29(tCP8) and addition of 
AcN PV/29. 
dent  rep l icat ion .  However ,  it was  a fo rmal  poss ib i l i ty  
wh ich  was  eas i ly  tes tab le .  We, there fore ,  eva luated  the 
rep l i ca t ion  of a p lasmid  (pVO2) conta in ing  VZV otis in 
insect  cel ls  (10). F igure 4 demonst ra tes  that  pVO2 was  
rep l i ca ted  in insect  ce l ls  in fected w i th  a mix ture  of bacu-  
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FIG. 3. Plasmid amplification in recombinant baculovirus-infected in- 
sect cells demonstrating that the inability of VZV gene 29 protein to 
replace lOP8 cannot be overcome by the presence of VZV gene 51 
protein. The experimental methods were performed as described in 
the legend to Fig. 2 and the plasmid transfected was pMC110. The "+" 
and "-"  above each lane indicates that he sample was digested (+) 
with the restriction enzyme Dpnl or not digested (-). Lanes 1 and 2, 
complete mixture of baculoviruses expressing the seven essential HSV- 
1 replication proteins; lanes 3 and 4, omission of AcUL29(ICP8); lanes 
5 and 6, omission of AcUL29(ICP8) and addition of AcNPV/29; lanes 7 
and 8, omission of both AcUL29(tCP8) and AcUL9 and addition of both 
AcNPV/29 and AcNPV/51; lanes 9 and 10, omission of AcUL29(ICP8) 
and addition of both AcNPV/2g and AcNPV/51; lanes 11 and 12, omis- 
sion of AcUL9 and addition of AcNPV/51 and AcNPV/29. 
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FIG. 4. Plasmid amplification in recombinant baculovirus-infected in- 
sect ceils demonstrating replication of a VZV origin-containing plasmid 
when gene 51 was substituted for UL9, but lack of replication when 
VZV gene 29 protein was substituted for ICP8. The e~<perimental meth- 
ods were performed as described in the legend to Fig. 2 except the 
cells were transfected with pVO2 (VZV oris). The "+" and " - "  above 
each lane indicates that the sample was digested (+) with the restric- 
tion enzyme Dpnl or not digested (-).  Lanes 1 and 2, complete mixture 
of HSV recombinant baculoviruses; lanes 3 and 4, omission of AcUL9; 
lanes 5 and 6, omission of AcUL9 and addition of AcNPV/51; lanes 7 
and 8, omission of AcUL29(ICP8); lanes 9 and 10, omission of AcUL29 
(lOPS) and addition of AcNPV/29; lanes 11 and 12, omission of AcUL29 
(lOPS) and addition of both AcNPV/29 and AcNPV/51. 
that gene 51 protein expressed in insect cells is func- 
tional. 
Stow and Davison showed that an HSV-1 origimcon- 
taining plasmid was not replicated in VZV-infected cells 
(10). This may have been because of the relative ineffi- 
ciency of the VZV infectious process or for other trivial 
reasons. However, it also may have reflected an intrinsic 
inability of the VZV replication machinery to utilize an 
HSV-1 origin. The OBP-binding sites of the HSV-1 and 
VZV origins are very similar, but there are sufficient struc- 
tural differences between the origins to support this idea 
(10). The results presented in this report argue against 
a functional difference in the HSV and VZV origins since 
both OBPs can use either origin as a substrate for initia- 
tion of DNA synthesis. 
The ability of gene 51 protein to substitute for UL9 
demonstrates that gene 51 protein is capable of function- 
ally participating in all of the UL9-protein and UL9-DNA 
interactions required for origin-dependent DNA synthe- 
sis. It has been reported that UL9 and lOP8 physically 
and functionally interact and that UL9 may interact with 
a cellular factor during origin-binding (18, 27). It is not 
known whether UL9 physically interacts with any of the 
other HSV replication proteins. In addition, since there 
are no published data which suggest hat UL9 is involved 
in the elongation phase of DNA replication, there is no 
compelling reason to invoke specific interactions of UL9 
with elongation factors such as the HSV DNA polymer- 
ase, etc. Our data lend support to the idea that UL9 is 
likely to be involved in a limited number of protein-pro- 
tein interactions during DNA synthesis. 
We did not attempt to quantitate the amount of plasmid 
replication that results in the presence of gene 51 protein 
relative to the amount that occurs with UL9. There are 
too many factors which could influence the level of repli- 
cation in this assay to enable us to determine whether 
gene 51 protein functions as efficiently as UL9. In multi- 
ple assays, however, we did not get the impression that 
experiments with gene 51 protein resulted in markedly 
reduced levels of Dpnl-resistant material after taking into 
account transfection efficiency. Recently, we have found 
that gene 51 can complement a UL9-minus HSV-1 mutant 
virus (D. Chen, E. Stabell, and P. D. Olivo, manuscript in 
preparation). The level of viral DNA synthesis and virus 
yield, however, was approximately 10-fold lower with 
gene 51 than with UL9. 
The inability of VZV gene 29 protein to functionally 
replace lOP8 in the origin-dependent DNA synthesis 
assay in insect cells is not surprising. Interestingly, 
however, gene 29 protein extracted from insect cells is 
fully soluble and characterization of its single-stranded 
DNA-binding properties reveals that it binds ssDNA in 
a manner quite similar to that of ICP8 (M. Horgan and 
P. D. Olive, manuscript submitted). It cannot be ruled 
out that the inability of gene 29 protein to substitute 
for ICP8 is due to expression of a nonfunctional protein 
because of a mutation that arose during generation of 
the recombinant baculovirus or for some other trivial 
reason. Although the ssDNA-binding activity of gene 
29 protein produced in insect cells supports the idea 
that it is a functional protein, it is possible that a muta- 
tion arose which affects a function unrelated to its 
ssDNA-binding activity. Definitively demonstrating that 
gene 29 protein is fully functional for DNA synthesis 
will depend on construction of baculoviruses which 
express the remaining five essential VZV replication 
proteins and development of VZV origin-dependent 
replication system in insect cells. 
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